This announcement is a separate document:
上海市锦天城律师事务所关于上海南方模式生物科技股份有限公司2022年限制性股票激励计划作废部分已授予尚未归属的限制性股票的法律意见书
Legal Opinion of Shanghai AllBright Law Firm on the Cancellation of Shanghai Southern Model Biotechnology Co., Ltd.'s 2022 Restricted Stock Incentive Plan and Granted Restricted Shares Not Owned
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated